These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7074228)

  • 1. Control of coronary flow by local factors during hypoxia with and without a fall in O2 consumption.
    Stowe DF
    Blood Vessels; 1982; 19(3):148-64. PubMed ID: 7074228
    [No Abstract]   [Full Text] [Related]  

  • 2. Theophylline increases coronary vascular tone in humans: evidence for a role of endogenous adenosine in flow regulation.
    Edlund A; Sollevi A
    Acta Physiol Scand; 1995 Nov; 155(3):303-11. PubMed ID: 8619329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart bioassay of effluent of isolated, perfused guinea pig hearts to examine the role of metabolites regulating coronary flow during hypoxia.
    Stowe DF
    Basic Res Cardiol; 1981; 76(4):359-64. PubMed ID: 7283937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is adenosine the mediator for the regulation of the coronary circulation and for the effect of coronarodilators? Review].
    Meisel M; Meisel P
    Pharmazie; 1974 Sep; 29(9):361-8. PubMed ID: 4213610
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of hypoxia-induced rise in adenosine release and flow by coronary dilators.
    Kukovetz WR; Pöch G
    Cardiology; 1971; 56(1):107-13. PubMed ID: 5152736
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential antagonism of cardiac actions of adenosine by theophylline.
    Bertolet BD; Belardinelli L; Avasarala K; Calhoun WB; Franco EA; Nichols WW; Kerensky RA; Hill JA
    Cardiovasc Res; 1996 Nov; 32(5):839-45. PubMed ID: 8944814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of dilazep on cardiac function, coronary circulation and myocardial energy metabolism].
    Katano Y; Takeda K; Otorii T; Horii D; Imai S
    Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):305-14. PubMed ID: 4858949
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine, theophylline, and perfusate pH in the isolated, perfused guinea pig heart.
    Merrill GF; Haddy FJ; Dabney JM
    Circ Res; 1978 Feb; 42(2):225-9. PubMed ID: 23224
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological basis of anti-anginal therapy. I. Physiopathological and pharmacological aspects (author's transl)].
    Penna M
    Rev Med Chil; 1978 Jul; 106(7):536-7. PubMed ID: 694281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of hexobendine on the coronary efficacy of generalized hypoxia as well as of i.cor. and i.v. single injections of adenosine in dogs].
    Raberger G; Weissel M; Kraupp O
    Arzneimittelforschung; 1973 Jun; 23(6):764-8. PubMed ID: 4740758
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of cyclic adenosine- and guanosine 3',5'-monophosphate on the normal and drug-increased coronary blood flow.
    Dietmann K; Roesch E; Schaumann W; Juhran W
    Biochem Pharmacol; 1972 Aug; 21(16):2193-6. PubMed ID: 4345801
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacology of 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-perhydro-1,4-diazepine (dilazep I.N.N.), a new coronary active substance].
    Lenke D; Brock N; Zechel HJ
    Arzneimittelforschung; 1972 Apr; 22(4):639-51. PubMed ID: 5068242
    [No Abstract]   [Full Text] [Related]  

  • 13. [The mechanism of coronary dilatating action of nifedipine].
    Kosche F; Raff WK; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):39-42. PubMed ID: 5066996
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
    Buyniski JP; Losada M; Bierwagen ME; Gardier RW
    J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of coronary vaso dilators on myocardial survival time in the rat under anoxia conditions].
    Urbaszek W; Tronicke E; Modersohn D; Uhlich C; Günther K; Pankau H
    Z Gesamte Inn Med; 1974 Jul; 29(13):521-7. PubMed ID: 4218417
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].
    Vater W; Kroneberg G; Hoffmeister F; Saller H; Meng K; Oberdorf A; Puls W; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1972 Jan; 22(1):1-14. PubMed ID: 4622472
    [No Abstract]   [Full Text] [Related]  

  • 17. A new generation of coronary vasodilators in stress perfusion imaging.
    Iskandrian AE
    Am J Cardiol; 2007 Jun; 99(11):1619-20. PubMed ID: 17531594
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological profile of razinodil as a possible new drug for ischemic myocardial diseases.
    Hashimoto K; Nakagawa Y; Tsukada T; Hashimoto T; Satoh H; Chin WP; Katano Y; Imai S
    Arzneimittelforschung; 1981; 31(5):781-5. PubMed ID: 7196735
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct demonstration by transthoracic Doppler echocardiography of adenosine-induced coronary steal in the collateral-dependent vessel.
    Takeuchi M; Yoshitani H; Otani S; Yoshikawa J
    Am J Cardiol; 2005 Jun; 95(11):1363-6. PubMed ID: 15904645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of 2,6-bis(diethanolamino)-4-piperidino-pyrimido(5,4-D)pyrimidine (RA233) on the coronary circulation of the acutely transplanted dog heart: comparison with dipyridamole and adenosine.
    Paoloni HJ; Wilcken DE
    J Pharmacol Exp Ther; 1972 Oct; 183(1):137-45. PubMed ID: 4562619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.